AKT1 and non-small cell lung carcinoma: Overexpression of miR-29b can target to inhibit the expression of FEM1B, further inhibit the activation of the FOXO1/AKT signaling pathway, inhibit the expression of VEGF, and promote the apoptosis of NSCLC cells.